Coya Therapeutics (COYA) Shares Outstanding (2021 - 2026)

Coya Therapeutics has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $23.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 40.25% year-over-year to $23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (up 40.25% YoY) and the FY2025 annual result came in at $16.7 million, changed 0.14% from the prior year.
• Shares Outstanding (Entity) advanced to $23.5 million in Q1 2026 per COYA's latest filing, from $16.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $23.5 million in Q1 2026 and troughed at $2.6 million in Q1 2022.
• A 5-year average of $11.9 million and a median of $14.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) increased 0.01% in 2022, then jumped 292.4% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $2.6 million in 2022, then surged by 292.4% to $10.2 million in 2023, then surged by 64.38% to $16.7 million in 2024, then advanced by 0.14% to $16.7 million in 2025, then jumped by 40.21% to $23.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $23.5 million, $16.7 million, and $16.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.